G protein-linked signaling pathways in bipolar and major depressive disorders

Frontiers in Genetics

Volumn 4, Issue DEC, 2013, Pages

  Tomita, Hiroaki ^a,b   Ziegler, Mary E ^a   Kim, Helen B ^a   Evans, Simon J ^c   Choudary, Prabhakara V ^d   Li, Jun Z ^c   Meng, Fan ^c   Dai, Manhong ^c   Myers, Richard M ^e   Neal, Charles R ^c,f   Speed, Terry P ^g   Barchas, Jack D ^h   Schatzberg, Alan F ⁱ   Watson, Stanley J ^c   Akil, Huda ^c   Jones, Edward G ^d   Bunney, William E ^a   Vawter, Marquis P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b TOHOKU UNIVERSITY   (Japan)

^c UNIVERSITY OF MICHIGAN   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e HUDSONALPHA INSTITUTE FOR BIOTECHNOLOGY   (United States)

^f UNIVERSITY OF HAWAII   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h WEILL CORNELL MEDICAL COLLEGE   (United States)

ⁱ STANFORD UNIVERSITY   (United States)

Author keywords

Bipolar disorder; Cyclic AMP; G protein coupled receptor (GPCR); GPR37; GPRC5B; Major depressive disorder; Phosphatidylinositol; Transcriptome

Indexed keywords

EID: 84892428680     PISSN: None     EISSN: 16648021     Source Type: Journal    
DOI: 10.3389/fgene.2013.00297     Document Type: Article

References (66)

1. Agam, G., Shaltiel, G., Kozlovsky, N., Shimon, H., Belmaker, R. H., and Shatiel, G. (2003). Lithium inhibitable enzymes in postmortem brain of bipolar patients. J. Psychiatr. Res. 37, 433-442. doi: 10.1016/S0022-3956(03)00044-X.
2. Aston, C., Jiang, L., and Sokolov, B. P. (2005). Transcriptional profiling reveals evidence for signaling and oligodendroglial abnormalities in the temporal cortex from patients with major depressive disorder. Mol. Psychiatry. 10, 309-322. doi: 10.1038/sj.mp.4001565.
3. Atz, M., Walsh, D., Cartagena, P., Li, J., Evans, S., Choudary, P., et al. (2007). Methodological considerations for gene expression profiling of human brain. J. Neurosci. Methods 163, 295-309. doi: 10.1016/j.jneumeth.2007.03.022.
4. Brauner-Osborne, H., and Krogsgaard-Larsen, P. (2000). Sequence and expression pattern of a novel human orphan G-protein-coupled receptor, GPRC5B, a family C receptor with a short amino-terminal domain. Genomics 65, 121-128. doi: 10.1006/geno.2000.6164.
5. Caberlotto, L., and Hurd, Y. L. (2001). Neuropeptide Y Y(1) and Y(2) receptor mRNA expression in the prefrontal cortex of psychiatric subjects. Relationship of Y(2) subtype to suicidal behavior. Neuropsychopharmacology 25, 91-97. doi: 10.1016/S0893-133X(00)00231-1.
6. Carvajal, C., Dumont, Y., and Quirion, R. (2006). Neuropeptide y: role in emotion and alcohol dependence. CNS Neurol. Disord. Drug Targets 5, 181-195. doi: 10.2174/187152706776359592.
7. Chang, A., Li, P. P., and Warsh, J. J. (2003). cAMP-Dependent protein kinase (PKA) subunit mRNA levels in postmortem brain from patients with bipolar affective disorder (BD). Brain Res. Mol. Brain Res. 116, 27-37. doi: 10.1016/S0169-328X(03)00211-0.
8. Choudary, P. V., Molnar, M., Evans, S. J., Tomita, H., Li, J. Z., Vawter, M. P., et al. (2005). Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression. Proc. Natl. Acad. Sci. U.S.A. 102, 15653-15658. doi: 10.1073/pnas.0507901102.
9. Dai, M., Wang, P., Boyd, A. D., Kostov, G., Athey, B., Jones, E. G., et al. (2005). Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data. Nucleic Acids Res. 33, e175. doi: 10.1093/nar/gni179.
10. Donati, R. J., and Rasenick, M. M. (2003). G protein signaling and the molecular basis of antidepressant action. Life Sci. 73, 1-17. doi: 10.1016/S0024-3205(03)00249-2.
11. Dwivedi, Y., Agrawal, A. K., Rizavi, H. S., and Pandey, G. N. (2002). Antidepressants reduce phosphoinositide-specific phospholipase C (PI-PLC) activity and the mRNA and protein expression of selective PLC beta 1 isozyme in rat brain. Neuropharmacology 43, 1269-1279. doi: 10.1016/S0028-3908(02)00253-8.
12. Dwivedi, Y., Mondal, A. C., Shukla, P. K., Rizavi, H. S., and Lyons, J. (2004). Altered protein kinase a in brain of learned helpless rats: effects of acute and repeated stress. Biol. Psychiatry 56, 30-40. doi: 10.1016/j.biopsych.2004.03.018.
13. Elhwuegi, A. S. (2004). Central monoamines and their role in major depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 28, 435-451. doi: 10.1016/j.pnpbp.2003.11.018.
14. Escriba, P. V., Ozaita, A., and Garcia-Sevilla, J. A. (2004). Increased mRNA expression of alpha2A-adrenoceptors, serotonin receptors and mu-opioid receptors in the brains of suicide victims. Neuropsychopharmacology 29, 1512-1521. doi: 10.1038/sj.npp.1300459.
15. Evans, S. J., Choudary, P. V., Neal, C. R., Li, J. Z., Vawter, M. P., Tomita, H., et al. (2004). Dysregulation of the fibroblast growth factor system in major depression. Proc. Natl. Acad. Sci. U.S.A. 101, 15506-15511. doi: 10.1073/pnas.0406788101.
16. Frazier, J. A., Ahn, M. S., DeJong, S., Bent, E. K., Breeze, J. L., and Giuliano, A. J. (2005). Magnetic resonance imaging studies in early-onset bipolar disorder: a critical review. Harv. Rev. Psychiatry 13, 125-140. doi: 10.1080/10673220591003597.
17. Frey, R., Metzler, D., Fischer, P., Heiden, A., Scharfetter, J., Moser, E., et al. (1998). Myo-inositol in depressive and healthy subjects determined by frontal 1H-magnetic resonance spectroscopy at 1.5 tesla. J. Psychiatr. Res. 32, 411-420. doi: 10.1016/S0022-3956(98)00033-8.
18. Friedman, E., and Wang, H. Y. (1996). Receptor-mediated activation of G proteins is increased in postmortem brains of bipolar affective disorder subjects. J. Neurochem. 67, 1145-1152. doi: 10.1046/j.1471-4159.1996.67031145.x.
19. Gould, T. D., and Manji, H. K. (2002). Signaling networks in the pathophysiology and treatment of mood disorders. J. Psychosom. Res. 53, 687-697. doi: 10.1016/S0022-3999(02)00426-9.
20. Gurevich, I., Tamir, H., Arango, V., Dwork, A. J., Mann, J. J., and Schmauss, C. (2002). Altered editing of serotonin 2C receptor pre-mRNA in the prefrontal cortex of depressed suicide victims. Neuron 34, 349-356. doi: 10.1016/S0896-6273(02)00660-8.
21. Harrison, P. J. (2002). The neuropathology of primary mood disorder. Brain 125(Pt 7), 1428-1449. doi: 10.1093/brain/awf149.
22. Harwood, A. J. (2005). Lithium and bipolar mood disorder: the inositol-depletion hypothesis revisited. Mol. Psychiatry 10, 117-126. doi: 10.1038/sj.mp.4001618.
23. Imai, Y., Soda, M., Hatakeyama, S., Akagi, T., Hashikawa, T., Nakayama, K. I., et al. (2002). CHIP is associated with Parkin, a gene responsible for familial Parkinson's disease, and enhances its ubiquitin ligase activity. Mol. Cell 10, 55-67. doi: 10.1016/S1097-2765(02)00583-X.
24. Imai, Y., Soda, M., Inoue, H., Hattori, N., Mizuno, Y., and Takahashi, R. (2001). An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of Parkin. Cell 105, 891-902. doi: 10.1016/S0092-8674(01)00407-X.
25. Iwamoto, K., Kakiuchi, C., Bundo, M., Ikeda, K., and Kato, T. (2004). Molecular characterization of bipolar disorder by comparing gene expression profiles of postmortem brains of major mental disorders. Mol. Psychiatry. 9, 406-416. doi: 10.1038/sj.mp.4001437.
26. Jope, R. S., Song, L., Li, P. P., Young, L. T., Kish, S. J., Pacheco, M. A., et al. (1996). The phosphoinositide signal transduction system is impaired in bipolar affective disorder brain. J. Neurochem. 66, 2402-2409.
27. Karege, F., Bovier, P., Rudolph, W., and Gaillard, J. M. (1996). Platelet phosphoinositide signaling system: an overstimulated pathway in depression. Biol. Psychiatry 39, 697-702. doi: 10.1016/0006-3223(95)00187-5.
28. Kim, S., and Webster, M. J. (2010). Correlation analysis between genome-wide expression profiles and cytoarchitectural abnormalities in the prefrontal cortex of psychiatric disorders. Mol. Psychiatry 15, 326-336. doi: 10.1038/mp.2008.99.
29. Konradi, C., Eaton, M., MacDonald, M. L., Walsh, J., Benes, F. M., and Heckers, S. (2004). Molecular evidence for mitochondrial dysfunction in bipolar disorder. Arch. Gen. Psychiatry 61, 300-308. doi: 10.1001/archpsyc.61.3.300.
30. Kuromitsu, J., Yokoi, A., Kawai, T., Nagasu, T., Aizawa, T., Haga, S., et al. (2001). Reduced neuropeptide Y mRNA levels in the frontal cortex of people with schizophrenia and bipolar disorder. Gene Expr. Patterns 1, 17-21. doi: 10.1016/S1567-133X(01)00003-5.
31. Leng, N., Gu, G., Simerly, R. B., and Spindel, E. R. (1999). Molecular cloning and characterization of two putative G protein-coupled receptors which are highly expressed in the central nervous system. Brain Res. Mol. Brain Res. 69, 73-83. doi: 10.1016/S0169-328X(99)00092-3.
32. Li, J. Z., Vawter, M. P., Walsh, D. M., Tomita, H., Evans, S. J., Choudary, P. V., et al. (2004). Systematic changes in gene expression in postmortem human brains associated with tissue pH and terminal medical conditions. Hum. Mol. Genet. 13, 609-616. doi: 10.1093/hmg/ddh065.
33. Lieb, K., Treffurth, Y., Berger, M., and Fiebich, B. L. (2002). Substance P and affective disorders: new treatment opportunities by neurokinin 1 receptor antagonists? Neuropsychobiology 45(Suppl. 1), 2-6. doi: 10.1159/000049254.
34. Lopez-Figueroa, A. L., Norton, C. S., Lopez-Figueroa, M. O., Armellini-Dodel, D., Burke, S., Akil, H., et al. (2004). Serotonin 5-HT1A, 5-HT1B, and 5-HT2A receptor mRNA expression in subjects with major depression, bipolar disorder, and schizophrenia. Biol. Psychiatry 55, 225-233. doi: 10.1016/j.biopsych.2003.09.017.
35. Marazziti, D., Di Pietro, C., Golini, E., Mandillo, S., Matteoni, R., and Tocchini-Valentini, G. P. (2009). Macroautophagy of the GPR37 orphan receptor and Parkinson disease-associated neurodegeneration. Autophagy 5, 741-742. doi: 10.4161/auto.5.5.8700.
36. Marazziti, D., Di Pietro, C., Mandillo, S., Golini, E., Matteoni, R., and Tocchini-Valentini, G. P. (2011). Absence of the GPR37/PAEL receptor impairs striatal Akt and ERK2 phosphorylation, DeltaFosB expression, and conditioned place preference to amphetamine and cocaine. FASEB J. 25, 2071-2081. doi: 10.1096/fj.10-175737.
37. Marazziti, D., Gallo, A., Golini, E., Matteoni, R., and Tocchini-Valentini, G. P. (1998). Molecular cloning and chromosomal localization of the mouse Gpr37 gene encoding an orphan G-protein-coupled peptide receptor expressed in brain and testis. Genomics 53, 315-324. doi: 10.1006/geno.1998.5433.
38. Marazziti, D., Golini, E., Mandillo, S., Magrelli, A., Witke, W., Matteoni, R., et al. (2004). Altered dopamine signaling and MPTP resistance in mice lacking the Parkinson's disease-associated GPR37/parkin-associated endothelin-like receptor. Proc. Natl. Acad. Sci. U.S.A. 101, 10189-10194. doi: 10.1073/pnas.0403661101.
39. Moore, G. J., Bebchuk, J. M., Parrish, J. K., Faulk, M. W., Arfken, C. L., Strahl-Bevacqua, J., et al. (1999). Temporal dissociation between lithium-induced changes in frontal lobe myo-inositol and clinical response in manic-depressive illness. Am. J. Psychiatry 156, 1902-1908.
40. Neal, Jr. C. R. Akil, H., and Watson, Jr. S. J. (2001). Expression of orphanin FQ and the opioid receptor-like (ORL1) receptor in the developing human and rat brain. J. Chem. Neuroanat. 22, 219-249. doi: 10.1016/S0891-0618(01)00135-1.
41. Pachter, J. A., Pai, J. K., Mayer-Ezell, R., Petrin, J. M., Dobek, E., and Bishop, W. R. (1992). Differential regulation of phosphoinositide and phosphatidylcholine hydrolysis by protein kinase C-beta 1 overexpression. Effects on stimulation by alpha-thrombin, guanosine 5'-O-(thiotriphosphate), and calcium. J. Biol. Chem. 267, 9826-9830.
42. Pandey, G. N., Dwivedi, Y., Pandey, S. C., Conley, R. R., Roberts, R. C., and Tamminga, C. A. (1997). Protein kinase C in the postmortem brain of teenage suicide victims. Neurosci. Lett. 228, 111-114. doi: 10.1016/S0304-3940(97)00378-9.
43. Pandey, G. N., Dwivedi, Y., Rizavi, H. S., Ren, X., Pandey, S. C., Pesold, C., et al. (2002). Higher expression of serotonin 5-HT(2A) receptors in the postmortem brains of teenage suicide victims. Am. J. Psychiatry 159, 419-429. doi: 10.1176/appi.ajp.159.3.419.
44. Peeters, P. J., Fierens, F. L., van den Wyngaert, I., Goehlmann, H. W., Swagemakers, S. M., Kass, S. U., et al. (2004). Gene expression profiles highlight adaptive brain mechanisms in corticotropin releasing factor overexpressing mice. Brain Res. Mol. Brain Res. 129, 135-150. doi: 10.1016/j.molbrainres.2004.06.038.
45. Quintero, J. L., Arenas, M. I., and Garcia, D. E. (2005). The antidepressant imipramine inhibits M current by activating a phosphatidylinositol 4, 5-bisphosphate (PIP(2))-dependent pathway in rat sympathetic neurones. Br. J. Pharmacol. 145, 837-843. doi: 10.1038/sj.bjp.0706239.
46. Racagni, G., and Popoli, M. (2008). Cellular and molecular mechanisms in the long-term action of antidepressants. Dialogues Clin. Neurosci. 10, 385-400.
47. Robbins, M. J., Charles, K. J., Harrison, D. C., and Pangalos, M. N. (2002). Localisation of the GPRC5B receptor in the rat brain and spinal cord. Brain Res. Mol. Brain Res. 106, 136-144. doi: 10.1016/S0169-328X(02)00420-5.
48. Rogers, M. A., Kasai, K., Koji, M., Fukuda, R., Iwanami, A., Nakagome, K., et al. (2004). Executive and prefrontal dysfunction in unipolar depression: a review of neuropsychological and imaging evidence. Neurosci. Res. 50, 1-11. doi: 10.1016/j.neures.2004.05.003.
49. Ruhe, H. G., Mason, N. S., and Schene, A. H. (2007). Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studies. Mol. Psychiatry 12, 331-359. doi: 10.1038/sj.mp.4001949.
50. Sano, T., Kim, Y. J., Oshima, E., Shimizu, C., Kiyonari, H., Abe, T., et al. (2011). Comparative characterization of GPRC5B and GPRC5CLacZ knockin mice; behavioral abnormalities in GPRC5B-deficient mice. Biochem. Biophys. Res. Commun. 412, 460-465. doi: 10.1016/j.bbrc.2011.07.118.
51. Serretti, A. (2002). Lithium long-term treatment in mood disorders: clinical and genetic predictors. Pharmacogenomics 3, 117-129. doi: 10.1517/14622416.3.1.117.
52. Sherrin, T., Heng, K. Y., Zhu, Y. Z., Tang, Y. M., Lau, G., and Tan, C. H. (2004). Cholecystokinin-B receptor gene expression in cerebellum, pre-frontal cortex and cingulate gyrus and its association with suicide. Neurosci. Lett. 357, 107-110. doi: 10.1016/j.neulet.2003.11.072.
53. Sibille, E., Arango, V., Galfalvy, H. C., Pavlidis, P., Erraji-Benchekroun, L., Ellis, S. P., et al. (2004).Gene expression profiling of depression and suicide in human prefrontal cortex. Neuropsychopharmacology 29, 351-361. doi: 10.1038/sj.npp.1300335.
54. Sinha, D., Wang, Z., Ruchalski, K. L., Levine, J. S., Krishnan, S., Lieberthal, W., et al. (2005). Lithium activates the Wnt and phosphatidylinositol 3-kinase Akt signaling pathways to promote cell survival in the absence of soluble survival factors. Am. J. Physiol. Renal Physiol. 288, F703-F713. doi: 10.1152/ajprenal.00189.2004.
55. Spleiss, O., van Calker, D., Scharer, L., Adamovic, K., Berger, M., and Gebicke-Haerter, P. J. (1998). Abnormal G protein alpha(s)-and alpha(i2)-subunit mRNA expression in bipolar affective disorder. Mol. Psychiatry 3, 512-520. doi: 10.1038/sj.mp.4000393.
56. Steen, V. M., Lovlie, R., Osher, Y., Belmaker, R. H., Berle, J. O., and Gulbrandsen, A. K. (1998). The polymorphic inositol polyphosphate 1-phosphatase gene as a candidate for pharmacogenetic prediction of lithium-responsive manic-depressive illness. Pharmacogenetics 8, 259-268.
57. Storey, J. D., and Tibshirani, R. (2003). Statistical significance for genomewide studies. Proc. Natl. Acad. Sci. U.S.A. 100, 9440-9445. doi: 10.1073/pnas.1530509100.
58. Takuwa, Y., Takuwa, N., and Sugimoto, N. (2002). The Edg family G protein-coupled receptors for lysophospholipids: their signaling properties and biological activities. J. Biochem. 131, 767-771. doi: 10.1093/oxfordjournals.jbchem.a003163.
59. Tomita, H., Vawter, M. P., Walsh, D. M., Evans, S. J., Choudary, P. V., Li, J., et al. (2004). Effect of agonal and postmortem factors on gene expression profile: quality control in microarray analyses of postmortem human brain. Biol. Psychiatry 55, 348-354. doi: 10.1016/j.biopsych.2003.10.013.
60. Vawter, M. P., Tomita, H., Meng, F., Bolstad, B., Li, J., Evans, S., et al. (2006). Mitochondrial-related gene expression changes are sensitive to agonal-pH state: implications for brain disorders. Mol. Psychiatry 11, 615, 663-679. doi: 10.1038/sj.mp.4001830.
61. Wise, A., Jupe, S. C., and Rees, S. (2004). The identification of ligands at orphan G-protein coupled receptors. Annu. Rev. Pharmacol. Toxicol. 44, 43-66. doi: 10.1146/annurev.pharmtox.44.101802.121419.
62. Xu, X., Muller-Taubenberger, A., Adley, K. E., Pawolleck, N., Lee, V. W., Wiedemann, C., et al. (2007). Attenuation of phospholipid signaling provides a novel mechanism for the action of valproic acid. Eukaryot Cell 6, 899-906. doi: 10.1128/EC.00104-06.
63. Young, L. T., Asghari, V., Li, P. P., Kish, S. J., Fahnestock, M., and Warsh, J. J. (1996). Stimulatory G-protein alpha-subunit mRNA levels are not increased in autopsied cerebral cortex from patients with bipolar disorder. Brain Res. Mol. Brain Res. 42, 45-50. doi: 10.1016/S0169-328X(96)00112-X.
64. Young, L. T., Li, P. P., Siu, K. P., Kish, S. J., and Warsh, J. J. (1993). Regional distribution of guanine nucleotide binding proteins (Gs and Gi alpha) in human brain: correlation with adenylyl cyclase activity. Neurochem. Int. 22, 285-291. doi: 10.1016/0197-0186(93)90057-C.
65. Zeng, Z., Su, K., Kyaw, H., and Li, Y. (1997). A novel endothelin receptor type-B-like gene enriched in the brain. Biochem. Biophys. Res. Commun. 233, 559-567. doi: 10.1006/bbrc.1997.6408.
66. Zhou, J. N., Riemersma, R. F., Unmehopa, U. A., Hoogendijk, W. J., van Heerikhuize, J. J., Hofman, M. A., et al. (2001). Alterations in arginine vasopressin neurons in the suprachiasmatic nucleus in depression. Arch. Gen. Psychiatry 58, 655-662. doi: 10.1001/archpsyc.58.7.655.